T-CELL LYMPHOMA
Clinical trials for T-CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new T-CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for T-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a cancer pill stop relapse after stem cell transplant?
Disease control Recruiting nowThis study tests whether the drug ruxolitinib, taken as a maintenance therapy after a stem cell transplant, can help prevent T-cell lymphoma from coming back and reduce the risk of graft-versus-host disease (GVHD), a common and serious complication where donor cells attack the pa…
Matched conditions: T-CELL LYMPHOMA
Phase: PHASE2 • Sponsor: Jonathan Brammer • Aim: Disease control
Last updated Apr 29, 2026 06:18 UTC
-
New hope for Tough-to-Treat T-Cell lymphoma: experimental drug ST-001 enters human testing
Disease control Recruiting nowThis early-phase trial is testing an experimental drug called ST-001 (a form of fenretinide) in about 46 adults with T-cell non-Hodgkin lymphoma that has returned or not responded to prior therapies. The main goals are to find the safest dose and to watch for side effects. Resear…
Matched conditions: T-CELL LYMPHOMA
Phase: PHASE1 • Sponsor: SciTech Development, Inc. • Aim: Disease control
Last updated Apr 29, 2026 06:17 UTC
-
Crushed cancer pill study aims to help kids who Can't swallow tablets
Knowledge-focused Recruiting nowThis study looks at how the body handles venetoclax when the tablet is crushed and mixed into a liquid. It includes children and young adults up to age 39 with blood cancers like leukemia or lymphoma who already take venetoclax this way. The goal is to measure drug levels in the …
Matched conditions: T-CELL LYMPHOMA
Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Knowledge-focused
Last updated Apr 28, 2026 13:02 UTC